Literature DB >> 6166723

Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus.

O Haller, H Arnheiter, I Gresser, J Lindenmann.   

Abstract

The efficacy of interferon in antiviral protection of newborn mice differing at the Mx locus was investigated. Adult mice bearing the allele Mx exhibit a high degree of specific resistance toward lethal challenge with influenza viruses. In contrast, newborn Mx carriers are virtually as susceptible to influenza viruses as newborn mice devoid of Mx. Resistance can be abrogated by treating adult animals with anti-interferon serum. Here, we provide direct evidence of a virus-specific effect of interferon in vivo: newborn mice carrying the resistance gene Mx could be protected against lethal influenza virus infection with doses of interferon that were not protective in the absence of Mx. The efficacy of interferon towards a picornavirus (encephalomyocarditis virus) and a rhabdovirus (vesicular stomatitis virus) was independent of Mx.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166723      PMCID: PMC2186399          DOI: 10.1084/jem.154.1.199

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  The relationship between interferon and virus virulence in influenza virus infections of the mouse.

Authors:  C McLaren; C W Potter
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

2.  A method for the large scale production of potent interferon preparations.

Authors:  M G Tovey; J Begon-Lours; I Gresser
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

3.  Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus.

Authors:  H Arnheiter; O Haller; J Lindenmann
Journal:  Virology       Date:  1980-05       Impact factor: 3.616

4.  Host gene influences sensitivity to interferon action selectively for influenza virus.

Authors:  O Haller; H Arnheiter; J Lindenmann; I Gresser
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

5.  Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression.

Authors:  O Haller; H Arnheiter; J Lindenmann
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice.

Authors:  J L Virelizier; I Gresser
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

7.  Host genotype influences immunomodulation by interferon.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  Nature       Date:  1980-03-13       Impact factor: 49.962

8.  Genetically determined, interferon-dependent resistance to influenza virus in mice.

Authors:  O Haller; H Arnheiter; I Gresser; J Lindenmann
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  22 in total

1.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 2.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  Characterization of an in vitro model of alphavirus infection of immature and mature neurons.

Authors:  Patty S Vernon; Diane E Griffin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells.

Authors:  E Meier; J Fäh; M S Grob; R End; P Staeheli; O Haller
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

5.  SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Authors:  Matthew B Frieman; Jun Chen; Thomas E Morrison; Alan Whitmore; William Funkhouser; Jerrold M Ward; Elaine W Lamirande; Anjeanette Roberts; Mark Heise; Kanta Subbarao; Ralph S Baric
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

6.  Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

Authors:  P R Wyde; M R Wilson; T R Cate
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice.

Authors:  V Martín; E Pascual; M Avia; G Rangel; A de Molina; A Alejo; N Sevilla
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

8.  Expression of interferon dependent resistance to influenza virus in mouse embryo cells.

Authors:  H Arnheiter; P Staeheli
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

9.  Pulmonary deposition and clearance of aerosolized interferon.

Authors:  P R Wyde; S Z Wilson; M J Kramer; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

10.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.